244 related articles for article (PubMed ID: 23932236)
41. The landscape of somatic mutations in Down syndrome-related myeloid disorders.
Yoshida K; Toki T; Okuno Y; Kanezaki R; Shiraishi Y; Sato-Otsubo A; Sanada M; Park MJ; Terui K; Suzuki H; Kon A; Nagata Y; Sato Y; Wang R; Shiba N; Chiba K; Tanaka H; Hama A; Muramatsu H; Hasegawa D; Nakamura K; Kanegane H; Tsukamoto K; Adachi S; Kawakami K; Kato K; Nishimura R; Izraeli S; Hayashi Y; Miyano S; Kojima S; Ito E; Ogawa S
Nat Genet; 2013 Nov; 45(11):1293-9. PubMed ID: 24056718
[TBL] [Abstract][Full Text] [Related]
42. Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.
Corazza F; Astolfi A; Libri V; Franzoni M; Serravalle S; Alessandroni R; Melchionda F; Pession A
Int J Hematol; 2014 Jun; 99(6):794-7. PubMed ID: 24771229
[TBL] [Abstract][Full Text] [Related]
43. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
Roy A; Roberts I; Norton A; Vyas P
Br J Haematol; 2009 Oct; 147(1):3-12. PubMed ID: 19594743
[TBL] [Abstract][Full Text] [Related]
44. Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome.
Grimm J; Heckl D; Klusmann JH
Front Oncol; 2021; 11():636633. PubMed ID: 33777792
[TBL] [Abstract][Full Text] [Related]
45. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.
Lum SH; Choong SS; Krishnan S; Mohamed Z; Ariffin H
Singapore Med J; 2016 Jun; 57(6):320-4. PubMed ID: 27353457
[TBL] [Abstract][Full Text] [Related]
46. Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children.
Ono R; Hasegawa D; Hirabayashi S; Kamiya T; Yoshida K; Yonekawa S; Ogawa C; Hosoya R; Toki T; Terui K; Ito E; Manabe A
Eur J Pediatr; 2015 Apr; 174(4):525-31. PubMed ID: 25266042
[TBL] [Abstract][Full Text] [Related]
47. Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports.
Tang H; Hu J; Liu L; Lv L; Lu J; Yang J; Lu J; Chen Z; Yang C; Chen D; Fu J; Wu J
Mol Cytogenet; 2023 Oct; 16(1):27. PubMed ID: 37858167
[TBL] [Abstract][Full Text] [Related]
48. Transient abnormal myelopoiesis in non-Down syndrome neonate.
Ohkawa T; Miyamoto S; Sugie M; Tomizawa D; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
Pediatr Int; 2015; 57(1):e14-7. PubMed ID: 25711269
[TBL] [Abstract][Full Text] [Related]
49. Myeloid Leukemia of Down Syndrome.
Kosmidou A; Tragiannidis A; Gavriilaki E
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444375
[TBL] [Abstract][Full Text] [Related]
50. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
Carpenter E; Valverde-Garduno V; Sternberg A; Mitchell C; Roberts I; Vyas P; Vora A
Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
[TBL] [Abstract][Full Text] [Related]
51. Mapping the cellular origin and early evolution of leukemia in Down syndrome.
Wagenblast E; Araújo J; Gan OI; Cutting SK; Murison A; Krivdova G; Azkanaz M; McLeod JL; Smith SA; Gratton BA; Marhon SA; Gabra M; Medeiros JJF; Manteghi S; Chen J; Chan-Seng-Yue M; Garcia-Prat L; Salmena L; De Carvalho DD; Abelson S; Abdelhaleem M; Chong K; Roifman M; Shannon P; Wang JCY; Hitzler JK; Chitayat D; Dick JE; Lechman ER
Science; 2021 Jul; 373(6551):. PubMed ID: 34244384
[TBL] [Abstract][Full Text] [Related]
52. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
53. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells.
Maclean GA; Menne TF; Guo G; Sanchez DJ; Park IH; Daley GQ; Orkin SH
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17567-72. PubMed ID: 23045682
[TBL] [Abstract][Full Text] [Related]
54. Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities.
Banno K; Omori S; Hirata K; Nawa N; Nakagawa N; Nishimura K; Ohtaka M; Nakanishi M; Sakuma T; Yamamoto T; Toki T; Ito E; Yamamoto T; Kokubu C; Takeda J; Taniguchi H; Arahori H; Wada K; Kitabatake Y; Ozono K
Cell Rep; 2016 May; 15(6):1228-41. PubMed ID: 27134169
[TBL] [Abstract][Full Text] [Related]
55. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
[TBL] [Abstract][Full Text] [Related]
56. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
Bombery M; Vergilio JA
Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
[TBL] [Abstract][Full Text] [Related]
57. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
[TBL] [Abstract][Full Text] [Related]
58. Transient Myeloproliferative Disorder: A Cytogenomic Update.
Zhao D; Shabsovich D; Peng E; Okabe A; Yang G; Tirado CA
J Assoc Genet Technol; 2020; 46(2):74-91. PubMed ID: 32526731
[TBL] [Abstract][Full Text] [Related]
59. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE
Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
[TBL] [Abstract][Full Text] [Related]
60. Mutation accumulation and developmental lineages in normal and Down syndrome human fetal haematopoiesis.
Hasaart KAL; Manders F; van der Hoorn ML; Verheul M; Poplonski T; Kuijk E; de Sousa Lopes SMC; van Boxtel R
Sci Rep; 2020 Jul; 10(1):12991. PubMed ID: 32737409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
